Will AI transform cancer drug discovery and fulfill the promise of precision oncology in a decade? With more than 10 million cancer deaths worldwide each year, the potential to accelerate the development of safer, more effective therapies has never been more important for our patients. Join us for the next Ellison #InsightsForum as leading experts in AI and cancer research explore how emerging technologies could reshape drug discovery and the future of cancer care. 📅 Friday, June 12 🕙 10-11:30 a.m. PT 🔗 Register: emila.org/insights

We just finalized our group presentation after a few intense and inspiring days of work with an incredible team. Grateful for the guidance of our amazing Advocate Mentor @ARosen380💚 and Scientist Mentor @MumenthalerSM🫶🏻 #AACR26 @AACR @AACRFoundation

Team EMI will be at #AACR2026! 🔬 We're excited to share new research, connect with collaborators, and engage in conversations at the intersection of AI, data, and cancer discovery. At AACR, we'll be showcasing our work in drug development and how we're accelerating promising ideas toward the clinic. If you’re attending, connect with our researchers, join their sessions, and stay tuned as we share highlights from the meeting. We’re proud to be part of a global community working to turn scientific insight into meaningful impact for patients. 💡 Featured: @MumenthalerSM, @AnnaBarker20

Our latest work is now published! Clinical trial data tumor-on-chip studies reveal a link between GABA signaling and invasiveness in Ras-altered colorectal cancer. Read here - rdcu.be/eB66U

We're thrilled to announce @USC has entered into an exclusive licensing agreement with the @EMILosAngeles for the rights to develop and commercialize a novel therapeutic drug for the treatment of #prostatecancer and related #diseases. Read more: stevens.usc.edu/news/usc-exe…

Join us @KeystoneSymp hashtag#TumorMetabolism: Environmental Influences and Therapeutic Vulnerabilities, this March in Vancouver! Watch the video for more details: youtu.be/PgfrK80BXGI

Deadlines are approaching for @KeystoneSymp #TumorMetabolism: Environmental Influences and Therapeutic Vulnerabilities, this March in Vancouver! See scholarship, abstract and discount reg dates: keysym.us/KSTumorMetab25 #KSTumorMetab25

Join us on Sept. 26 for our @EITLosAngeles #InsightsForum, where expert oncologists & researchers will discuss if AI is living up to its potential in cancer research and care. What’s holding it back, & how can we fix it? Register: eirf.org/insights

Working with a great team to organize @KeystoneSymp #TumorMetabolism: Environmental Influences and Therapeutic Vulnerabilities, March 2025! Join us to explore emerging research in Vancouver! keysym.us/KSTumorMetab25

We're excited to host our June 6 @EITLosAngeles #InsightsForum during #NationalCancerSurvivorMonth, where survivors and researchers will discuss how we can break down barriers to #PrecisionMedicine and other advanced cancer treatments. Register now: eirf.org/insights

Don’t miss out – applications are due by March 8! Check out eirf.org/education for more info.

Calling all aspiring scientists and innovators 📣 Our @eitlosangeles #JuniorFellows program is a free summer internship for rising high school seniors to experience hands-on learning in state-of-the-art labs and work alongside our researchers and physicians.

Advances in #syntheticbiology and #systemsbiology can be used to model the dynamic tumor microenvironment, paving the way to a more informed understanding of cancer diagnosis, treatment and prevention. In a new perspective for @natrevbioeng, our @MumenthalerSM, @MouseModeler and fellow co-authors explore how the engineering of synthetic living materials will address critical challenges in #cancerbiology and what inclusive design strategies might look like moving forward. Read the full article here ➡️ nature.com/articles/s44222-0…

In their new Review, Shelly Peyton, Krish Roy, Shannon Mumenthaler and colleagues discuss the engineering of synthetic living materials and their applications in cancer biology @peytonlab @KrishRoyLab @MumenthalerSM @thechowlab @seidlits go.nature.com/46A9gjV

Cancer Microenvironment: Jasmin Fisher and Shannon M. Mumenthaler will address this topic in a plenary session at the AACR Special Conference on Translating Cancer Evolution and Data Science (December 3-6, Boston). Learn more: bit.ly/3ttAjPF #AACRevol23 @MumenthalerSM

#TeamEllison will be at #AACR23 over the next week, sharing their latest research and connecting with the global #cancerresearch community working to advance the frontiers of #cancerscience and medicine! Follow along here & learn more about their work at: bit.ly/3ogBLTf

Learn more about how groundbreaking #OrganOnChip technology is helping scientists predict human responses to drugs, facilitating a new era in #cancerresearch and #drugdiscovery, in a recent article by #EllisonInstitute researchers in @TrendsinBiotech. bit.ly/3KurmMF

And here it is!!! Proud to share our new method paper to profile drug response heterogeneity in cancer samples from standard bulk drug-screen measurements. @freeges @EvenMMyklebust @KjetilTasken @jenserink @Mariase55115145 @Dagim26 @l_schmiester @MumenthalerLab @OCBE_UniOslo

Gonna be at #SLAS2023? Want to catch up on all the coolest developments in high-content #bioimageanalysis? All on Monday! 11-11:30AM - Piximi, deep learning in the browser 1-2PM - HCS/HCA Special Interest Group - on image data 2-3 - Hear about the JUMP Consortium See you there!

@EllisonInst researchers Carly Strelez, Hannah Y. Jiang, and @MumenthalerLab take a look at what groundbreaking #OrganonChip technology has done for innovation in #drugdiscovery over the last 10 years. Read more in @TrendsinBiotech: bit.ly/3KurmMF